Literature DB >> 10429736

Review article: an integrated approach to the irritable bowel syndrome.

D A Drossman1.   

Abstract

Our understanding of the pathophysiology of irritable bowel syndrome (IBS) has evolved from a disorder of motility to a more integrated understanding of enhanced motility and visceral hypersensitivity associated with brain-gut dysfunction. Psychosocial factors contribute to the predisposition, precipitation and perpetuation of IBS symptoms, and affect the clinical outcome. Newer brain imaging techniques (e.g. PET, fMRI) may help us understand the relationship between altered emotional states with pain enhancement and other gastrointestinal symptoms. Diagnosis using symptom-based (e.g. Rome) criteria and a conservative diagnostic approach is recommended. Treatment is based on an effective physician-patient relationship and a combined pharmacological and behavioural approach. Newer medications acting at the 5-HT receptor may help in reducing pain and bowel dysfunction. For more severe pain, antidepressants may be considered.

Entities:  

Mesh:

Year:  1999        PMID: 10429736     DOI: 10.1046/j.1365-2036.1999.0130s2003.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  26 in total

1.  Diagnosing irritable bowel syndrome: what's too much, what's enough?

Authors:  Susan Lucak
Journal:  MedGenMed       Date:  2004-03-12

Review 2.  Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions.

Authors:  Lena Ohman; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-01-26       Impact factor: 46.802

Review 3.  Clinical pharmacokinetics of tegaserod, a serotonin 5-HT(4) receptor partial agonist with promotile activity.

Authors:  Silke Appel-Dingemanse
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  Functional abdominal pain.

Authors:  P J Matthews; Q Aziz
Journal:  Postgrad Med J       Date:  2005-07       Impact factor: 2.401

Review 5.  Drug treatment options for irritable bowel syndrome: managing for success.

Authors:  R C Dunphy; G N Verne
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

6.  Reversal of Irritable Bowel Syndrome, Sleep Disturbance, and Fatigue With an Elimination Diet, Lifestyle Modification, and Dietary Supplements: A Case Report.

Authors:  Stephanie Davis
Journal:  Integr Med (Encinitas)       Date:  2016-10

Review 7.  New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments.

Authors:  Michael D Crowell; Lucinda Harris; Michael P Jones; Lin Chang
Journal:  Curr Gastroenterol Rep       Date:  2005-08

8.  Anxiety and depression are related to autonomic nervous system function in women with irritable bowel syndrome.

Authors:  Monica E Jarrett; Robert L Burr; Kevin C Cain; Vicky Hertig; Pam Weisman; Margaret M Heitkemper
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

9.  A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial.

Authors:  Solveig C Ligaarden; Lars Axelsson; Kristine Naterstad; Stian Lydersen; Per G Farup
Journal:  BMC Gastroenterol       Date:  2010-02-10       Impact factor: 3.067

Review 10.  Role of serotonin in the pathophysiology of the irritable bowel syndrome.

Authors:  Michael D Crowell
Journal:  Br J Pharmacol       Date:  2004-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.